16-1777134-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080861.4(SPSB3):c.1031C>T(p.Pro344Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,611,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080861.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPSB3 | NM_080861.4 | c.1031C>T | p.Pro344Leu | missense_variant | 7/7 | ENST00000566339.6 | |
EME2 | NM_001257370.2 | c.*896G>A | 3_prime_UTR_variant | 8/8 | ENST00000568449.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPSB3 | ENST00000566339.6 | c.1031C>T | p.Pro344Leu | missense_variant | 7/7 | 1 | NM_080861.4 | P1 | |
EME2 | ENST00000568449.7 | c.*896G>A | 3_prime_UTR_variant | 8/8 | 1 | NM_001257370.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152216Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000325 AC: 8AN: 246394Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134332
GnomAD4 exome AF: 0.0000480 AC: 70AN: 1459342Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 28AN XY: 726018
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152216Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2023 | The c.1031C>T (p.P344L) alteration is located in exon 7 (coding exon 6) of the SPSB3 gene. This alteration results from a C to T substitution at nucleotide position 1031, causing the proline (P) at amino acid position 344 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at